PT88383A - Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet - Google Patents

Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet

Info

Publication number
PT88383A
PT88383A PT88383A PT8838388A PT88383A PT 88383 A PT88383 A PT 88383A PT 88383 A PT88383 A PT 88383A PT 8838388 A PT8838388 A PT 8838388A PT 88383 A PT88383 A PT 88383A
Authority
PT
Portugal
Prior art keywords
von
methylpropionsaeure
chlorbenzamido
enthaltenden
geeignet
Prior art date
Application number
PT88383A
Other languages
English (en)
Other versions
PT88383B (pt
Inventor
Walter Beck
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of PT88383A publication Critical patent/PT88383A/pt
Publication of PT88383B publication Critical patent/PT88383B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT88383A 1987-09-01 1988-08-31 Processo para a preparacao de composicoes farmaceuticas contendo acido 2-<4-{2-(4-clorobenzamido)-etil}-fenoxi>-2-metil-propoionico apropriadas para o tratamento de diabetes PT88383B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873729209 DE3729209A1 (de) 1987-09-01 1987-09-01 Verwendung von bezafibrat zur behandlung von diabetes

Publications (2)

Publication Number Publication Date
PT88383A true PT88383A (pt) 1989-07-31
PT88383B PT88383B (pt) 1992-10-30

Family

ID=6334986

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88383A PT88383B (pt) 1987-09-01 1988-08-31 Processo para a preparacao de composicoes farmaceuticas contendo acido 2-<4-{2-(4-clorobenzamido)-etil}-fenoxi>-2-metil-propoionico apropriadas para o tratamento de diabetes

Country Status (16)

Country Link
US (1) US5304575A (pt)
EP (1) EP0305890B1 (pt)
JP (1) JP2647918B2 (pt)
KR (1) KR890004690A (pt)
AT (1) ATE95694T1 (pt)
AU (1) AU610228B2 (pt)
CA (1) CA1323575C (pt)
DE (2) DE3729209A1 (pt)
DK (1) DK472688A (pt)
ES (1) ES2059457T3 (pt)
HU (1) HU200687B (pt)
IE (1) IE62189B1 (pt)
IL (1) IL87566A0 (pt)
PH (1) PH24568A (pt)
PT (1) PT88383B (pt)
ZA (1) ZA886459B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
WO1998005331A2 (en) * 1996-08-02 1998-02-12 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
WO1999005161A1 (en) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
EP1246792B1 (en) 2000-01-13 2014-08-13 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ES2614603T3 (es) 2002-02-20 2017-06-01 Emisphere Technologies, Inc. Procedimiento de administración de moléculas GLP-1
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US20070197602A1 (en) * 2004-02-09 2007-08-23 Hashime Kanazawa Combined pharmaceutical composition
FR2898894B1 (fr) * 2006-03-24 2008-06-06 Genfit Sa Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
US10098860B2 (en) * 2016-07-20 2018-10-16 Cipla Limited Bezafibrate for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149070C3 (de) * 1971-10-01 1978-03-23 Boehringer Mannheim Gmbh, 6800 Mannheim Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel
JPS56145261A (en) * 1980-04-10 1981-11-11 Kaken Pharmaceut Co Ltd Novel oxyacetic acid derivative, its preparation, and lowering agent of lipid in blood comprising it as active ingredient

Also Published As

Publication number Publication date
ZA886459B (en) 1989-05-30
EP0305890B1 (de) 1993-10-13
DE3729209C2 (pt) 1989-08-03
PT88383B (pt) 1992-10-30
DK472688D0 (da) 1988-08-24
AU610228B2 (en) 1991-05-16
HUT47427A (en) 1989-03-28
DE3729209A1 (de) 1989-03-09
IE62189B1 (en) 1994-12-28
KR890004690A (ko) 1989-05-09
DK472688A (da) 1989-03-02
ATE95694T1 (de) 1993-10-15
JPS6471813A (en) 1989-03-16
DE3884895D1 (de) 1993-11-18
HU200687B (en) 1990-08-28
JP2647918B2 (ja) 1997-08-27
EP0305890A3 (en) 1990-08-22
EP0305890A2 (de) 1989-03-08
IE882529L (en) 1989-03-01
US5304575A (en) 1994-04-19
AU2158688A (en) 1989-05-25
IL87566A0 (en) 1989-01-31
CA1323575C (en) 1993-10-26
PH24568A (en) 1990-08-03
ES2059457T3 (es) 1994-11-16

Similar Documents

Publication Publication Date Title
DE68911103T2 (de) Verwendung von Fettsäuren zur Behandlung von myalgischer Enzephalomyelitis.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
PT88383A (pt) Verfahren fuer die herstellung von 2-[4-&lt;2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE69106586D1 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
DE69126646T2 (de) Biologisches Verfahren zur Herstellung von optisch-aktiver Milchsäure
DE3785132D1 (de) Herstellung optisch aktiver cyclopropancarbonsaeuren.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
ATE148628T1 (de) 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten
DE3854121T2 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE78395T1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE69008466T2 (de) Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen.
DE3787954D1 (de) Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen.
DE3866653D1 (de) Zusammensetzung fuer die behandlung der epidermis.
DK275784D0 (da) 6-(aminomethyl)penicillansyre-1,1-dioxid-estere, som er hydrolyserbare under fysiologiske betingelser, og aminobeskyttede 6-(aminomethyl)penicillansyre-forbindelser til anvendelse som mellemprodukter herfor
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
DE59006944D1 (de) Verfahren zur Herstellung von 2-Mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren Ester.
ATE84784T1 (de) Verfahren zur herstellung von 2-(2-chloroaethoxy)- benzosulfonamid.
ATE95061T1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
ATE58476T1 (de) Verwendung von doxaminol zur herstellung eines arzneimittels zur behandlung der peripheren arteriellen verschlusskrankheit.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920413

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20031031